Dyslipidemia is a significant risk factor for the progression of cardiovascular disease, particularly when associated with other risk factors. An understanding of the pathophysiology and risks for patients with atherosclerotic diseases of undertreated dyslipidemia is essential for the healthcare provider. In this article, a review of epidemiologic data regarding the role of lipid levels in cardiovascular disease prognosis is presented. A familiarity with current dietary and drug treatment of lipid disorders is at the core of an evidence-based approach to dyslipidemia management in the patient with established cardiovascular diseases.
Skip Nav Destination
Cardiovascular Nursing| February 01 2001
Nutritional and Medical Therapy for Dyslipidemia in Patients With Cardiovascular Disease
Paul Logan, MSN, CRNP, CS, CCRN;
From Norristown Cardiovascular Associates, Norristown, Pennsylvania, and University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania.
Reprint requests to Paul Logan, MSN, CRNP, CS, CCRN, Norristown Cardiovascular Associates, 1544 DeKalb Street, Norristown, PA 19401.
Search for other works by this author on:
AACN Adv Crit Care (2001) 12 (1): 40–52.
Paul Logan, Sean Clarke; Nutritional and Medical Therapy for Dyslipidemia in Patients With Cardiovascular Disease. AACN Adv Crit Care 1 February 2001; 12 (1): 40–52. doi:
Download citation file:
Don't already have an account? Register